Wotton Paul K
CIK: 0001300997
Associated companies
Transaction History
| VCEL | ▼ Sell | Open Market | 2,500 | $83K | 5/11/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 7,500 | $245K | 5/11/2026 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,200 | — | 4/29/2026 | View on chart |
| VCEL | ▼ Sell | Open Market | 2,500 | $95K | 12/3/2025 | View on chart |
| VCEL | ▼ Sell | Open Market | 2,500 | $95K | 12/2/2025 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,200 | — | 4/30/2025 | View on chart |
| VCEL | ▼ Sell | Open Market | 2,600 | $153K | 12/4/2024 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 3,200 | — | 5/1/2024 | View on chart |
| VCEL | ▼ Sell | Open Market | 5,000 | $187K | 12/14/2023 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,600 | — | 4/27/2023 | View on chart |
| VCEL | ▲ Buy | Option Exercise | 2,600 | — | 4/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Truist lowers Vericel price target to $52
Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.
Truist lowers Vericel price target to $52. Truist Securities maintained its positive stance on Vericel but reduced its price target to $52. This adjustment places the new target below the current average analyst estimate of $60.57. The move reflects a cautious outlook despite the firm's continued positive assessment of the company.